Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistanceAyumi Kanemaru(Kumamoto University), Hirofumi Jono(Kumamoto City Hospital)Cancer Cell InternationalNovember 15, 202210.1186/s12935-022-02781-xCited by 10SaveCiteExport RISWatch citationsRelated PapersIdentification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup>and CD8<sup>+</sup>T-cell epitopes and eliciting CD4<sup>+</sup>T-cell immunity in patients with malignant disease|OncoImmunology|2014|17PKCθ Synergizes with TLR-Dependent TRAF6 Signaling Pathway to Upregulate MUC5AC Mucin via CARMA1|PLoS ONE|2012|10